Cantor


Snap Inc (SNAP) Gains a Bull on Better Risk/Reward

Snap Inc (NYSE:SNAP) shares were rising roughly 7% yesterday and continue to rise 3% in pre-market trading today on back of the needle-moving …

TherapeuticsMD Inc (TXMD) VVA Drug Could Be Approved by Early 2018: Cantor

Largely dismissing investor skepticism questioning the viability of TherapeuticsMD Inc (NYSEMKT:TXMD) vaginal soft gel capsule TX-004, analyst William Tanner of Cantor is confident …

Most Important Part of Novavax, Inc. (NVAX) 2Q Update May Point to NanoFlu, Wagers Cantor

Novavax, Inc. (NASDAQ:NVAX) shares were rising 5% in after-hours trading yesterday after the company reported second-quarter financials and provided investors with an update …

Snap Inc (SNAP) Investors Shouldn’t Throw In The Towel Yet: Cantor

Cantor analyst Kip Paulson is out with a new research note on Snap Inc (NYSE:SNAP) ahead of the media mogul’s release of second quarter …

Cantor Counts on GW Pharmaceuticals PLC- ADR (GWPH) Upcoming Catalysts

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) shares were falling 2% yesterday after the biotech company handed over its third-fiscal quarter print for the year, …

Cantor Weighs in on Zynerba Pharmaceuticals Inc (ZYNE) as Phase 2 Readouts Approaching

Cantor analyst Elemer Piros weighs in with a few insight on Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), after the drug maker reported second-quarter results and reiterated its …

Cantor Highlights 3 Reasons To Own Valeant Pharmaceuticals Intl Inc (VRX)

Cantor analyst Louise Chen had the opportunity to discuss this morning with Valeant Pharmaceuticals Intl Inc (NYSE:VRX) management regarding some concern that formulary changes …

Cantor Remains Bullish on TherapeuticsMD Inc (TXMD) as Investors Await Clarity on TX-004

Cantor analyst William Tanner is out with a research note on shares of TherapeuticsMD Inc (NYSEMKT:TXMD), after the company provided an update regarding the New Drug Application …

Ocular Therapeutix Inc (OCUL) Soars 20% After Making Move to Resolve Dextenza Manufacturing Issues; Cantor Weighs In

Ocular Therapeutix Inc (NASDAQ:OCUL) shares may have been falling almost 9% at the close on the heels of a class action lawsuit filed …

This Analyst Sees 200% Upside for Synergy Pharmaceuticals Inc (SGYP)

In a research report released Thursday, Cantor analyst William Tanner initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) with an Overweight rating and price target …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts